Chemclin

Beijing, China Founded: 2007 • Age: 19 yrs Acquired By Actis
In vitro diagnostic instruments and reagents are provided by Chemclin.
Request Access

About Chemclin

Chemclin is a company based in Beijing (China) founded in 2007 was acquired by Actis in June 2013.. Chemclin has raised $312.54 million across 3 funding rounds from investors including CICC, Actis and Orbimed.

  • Headquarter Beijing, China
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $312.54 M (USD)

    in 3 rounds

  • Latest Funding Round
    $292.04 M (USD), Series C

    Aug 13, 2018

  • Investors
    CICC

    & 8 more

  • Employee Count
    Employee Count
  • Acquired by
    Actis

    (Jun 01, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Chemclin

Chemclin has successfully raised a total of $312.54M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $292.04 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series C — $292.0M
  • First Round

    (01 Apr 2007)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2018 Amount Series C - Chemclin Valuation

investors

Oct, 2008 Amount Series B - Chemclin Valuation

investors

Apr, 2007 Amount Series A - Chemclin Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Chemclin

Chemclin has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include CICC, Actis and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity & venture capital firm
Founded Year Domain Location
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
Founded Year Domain Location
VC firm that does investment in early stage companies in the US & China
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Chemclin

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Chemclin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chemclin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Chemclin

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chemclin

Frequently Asked Questions about Chemclin

When was Chemclin founded?

Chemclin was founded in 2007.

Where is Chemclin located?

Chemclin is headquartered in Beijing, China.

Is Chemclin a funded company?

Chemclin is a funded company, having raised a total of $312.54M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Apr 01, 2007.

What does Chemclin do?

Chemclin, founded in 2007 as a subsidiary of China Diagnostics Medical Corporation, is based in Beijing, China. Diagnostic reagents and instruments for in vitro applications are developed, manufactured, and distributed by the company. Coverage includes chemiluminescence immunoassays, radioimmunoassay kits, and clinical chemistry assays. Systems and reagents address infectious diseases, tumor markers, liver fibrosis, diabetes, thyroid function, and fertility testing.

Who are Chemclin's investors?

Chemclin has 9 investors. Key investors include CICC, Actis, Orbimed, WI Harper Group, and Free Trade Zone Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available